Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imatinib's last lessons? A roadmap to cure.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Effects of Fitlight training on cognitive-motor performance in élite judo athletes.

Heliyon·2024
Same author

Global longitudinal strain for prediction of mortality in ST-segment elevation myocardial infarction and aortic stenosis patients: two sides of the same coin.

European review for medical and pharmacological sciences·2023
Same author

Anisotropic hybridization probed by polarization dependent x-ray absorption spectroscopy in VI<sub>3</sub>van der Waals Mott ferromagnet.

Journal of physics. Condensed matter : an Institute of Physics journal·2023
Same author

Pediatric robotic-assisted laparoscopic ureterocalycostomy: Salient tips and technical modifications for optimal repair.

BJUI compass·2022
Same author

Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations.

Journal of endocrinological investigation·2022

Related Experiment Video

Updated: May 25, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Correlation between clinical presentation and delayed-enhancement MRI pattern in myocarditis.

L Natale1, A De Vita, C Baldari

  • 1Dipartimento di Bioimmagini e Scienze Radiologiche, Università Cattolica S. Cuore, Rome, Italy. luiginatale@mac.com

La Radiologia Medica
|February 14, 2012
PubMed
Summary

Magnetic resonance imaging (MRI) helps diagnose myocarditis and predict outcomes. Late enhancement on MRI is a key indicator of negative cardiac remodeling in patients with confirmed myocarditis.

More Related Videos

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Related Experiment Videos

Last Updated: May 25, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pathology

Background:

  • Myocarditis diagnosis is challenging due to variable presentations and delayed detection.
  • Clinical courses range from acute coronary syndromes to heart failure and arrhythmias.
  • Accurate prognostic factors are crucial for managing myocarditis patients.

Purpose of the Study:

  • To identify prognostic factors using magnetic resonance imaging (MRI) in bioptically proven myocarditis.
  • To evaluate prognostic indicators at presentation and after 6 months.
  • To correlate imaging findings with clinical outcomes.

Main Methods:

  • Fifty-six myocarditis patients with diverse presentations were enrolled.
  • Comprehensive assessments included echocardiography, coronarography, biopsy, and contrast-enhanced MRI.
  • Clinical and echocardiographic follow-up was conducted at 6 months.

Main Results:

  • Patients were categorized into positive and negative remodeling groups based on cardiac volumes and ejection fraction at 6 months.
  • Late gadolinium enhancement on MRI independently predicted negative remodeling.
  • This suggests MRI can identify patients at higher risk for adverse outcomes.

Conclusions:

  • Contrast-enhanced MRI is valuable for diagnosing myocarditis.
  • MRI serves as a significant prognostic indicator in suspected myocarditis cases.
  • Late enhancement on MRI is a key predictor of long-term cardiac remodeling.